TEVA PHARMACEUTICAL INDUSTRIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.55 USD | +1.29% |
|
+0.36% | +58.52% |
| 01/07 | Sector Update: Health Care Stocks Retreat Late Afternoon | MT |
| 01/07 | Sector Update: Health Care Stocks Slipping in Afternoon Trading | MT |
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
Pharmaceuticals
Calendar
07/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.55
USD
Average target price
18.74
USD
Spread / Average Target
+13.21%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +58.52% | 1.85TCr | |
| +55.55% | 82TCr | |
| +42.31% | 64TCr | |
| -6.83% | 35TCr | |
| +17.15% | 32TCr | |
| +7.09% | 30TCr | |
| +14.02% | 24TCr | |
| +1.64% | 22TCr | |
| +13.66% | 22TCr | |
| +7.87% | 17TCr |
- Stock Market
- Equities
- TEVA Stock
- News Teva Pharmaceutical Industries Limited
- Jefferies Downgrades Teva Pharmaceutical Industries to Hold From Buy, Adjusts Price Target to $12 From $10
